Peripheral Artery Disease Market Precise Outlook 2021 to 2030


Posted March 21, 2021 by sheshk234

At an estimated value of over USD 4.53 billion in 2019, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 6.2% and valued at over USD 8.78 billion over the forecast year 2020-2030.

 
At an estimated value of over USD 4.53 billion in 2019, the Global Peripheral Artery Disease Market is predicted to thrive at a CAGR of 6.2% and valued at over USD 8.78 billion over the forecast year 2020-2030.

Peripheral artery disease is a common circulatory problem that causes narrowing of the peripheral arteries. Generally, it affects arteries in the legs and sometimes affect the arteries carrying blood from heart to arms, kidneys, head, and stomach. It is mainly caused by the deposition of fats or plaques in the artery walls. The exercise, tobacco cessation, and a healthy diet are the main treatments for this disease; however, when such treatments aren't enough, medication or surgery can be helpful.

Access Full Description of this report at:-

https://www.nextmsc.com/report/peripheral-artery-disease-market

Top Companies: Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc., Terumo Corporation, Cook Medical, Becton, Dickinson and Company, Koninklijke Philips N.V, AngioDynamics, Inc., Biotronik and others.

The global peripheral artery disease market share is segmented on the basis of type, and geography. On the basis of type, the market is segmented into peripheral angioplasty balloons, peripheral catheters, inferior vena cava (IVC) filters, peripheral stents, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.

Request sample copy of this report at:-

https://www.nextmsc.com/peripheral-artery-disease-market/request-sample

In terms of geography, North America held major share of the market in 2019. This is attributed to higher healthcare expenditure and the growing occurrence of minimally invasive surgeries in the region. However, Asia-pacific is expected to be the fastest growing market due to the existence of large patient pool along with unmet medical needs. Moreover, significant growth in population together with growing geriatric population is expected to be opportunistic for the market growth in this region during the forecast period.

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Shesh
Country India
Categories Health
Tags peripheral artery disease market
Last Updated March 21, 2021